As 2,000 experts in pathology and laboratory medicine from around the world converge in Boston this week for stimulating presentations, education sessions, and lively discussions on scientific research, trends, and issues facing the pathology and medical laboratory professions at the ASCP Annual Meeting, conference organizers seek to emphasize themes that will help the pathologist and the laboratory professional understand their roles in the future of diagnostic medicine around personalized care.
Blair Holladay, PhD, SCT(ASCP), spoke with ADVANCE about the organization’s goal of moving its annual conference toward a comprehensive meeting for all practitioners in the laboratory, pathologists, laboratory professionals, clinical scientists, even the educators as well as the students, residents -- to move it to one conglomerate meeting, as opposed to a focus just on pathologists.
At the same time, meeting organizers strove to migrate the conference content towards “what we consider to be the advance of pathology in the space of precision diagnostics or personalized medicine that requires we make appropriate choices and offer the right test at the right time for the right patient,” Holladay noted.
Part of the future for pathology is helping laboratory professionals and pathologists recognize their role as consultants and encouraging them to play a more provocative role with the clinicians about appropriate decisions regarding laboratory tests as well as recommendations particularly around theradiagnostics and even therapeutic intervention.
Pathologists often have information clinicians can utilize to make better decisions around personalized medicine, Holladay stressed. “Personalized care is obviously the most important focus for the future of pathology because we want patients to get concierge care as opposed to just your standard fare menu of therapeutic choices, you want to have the right test at the right time for the right patient, that’s why we’re really shifting the focus of our meeting, so its very comprehensive and it has that patient-centric modality.”